Opportunity ID: 258511

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-14-026
Funding Opportunity Title: Development of Novel Therapeutics for Select Pathogens (R21/R33)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 25, 2014
Last Updated Date:
Original Closing Date for Applications: Oct 20, 2014
Current Closing Date for Applications: Oct 20, 2014
Archive Date: Nov 20, 2014
Estimated Total Program Funding: $3,100,000
Award Ceiling: $300,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public and State controlled institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
County governments
Independent school districts
Private institutions of higher education
For profit organizations other than small businesses
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to support basic to translational research focused on development of novel therapeutics against select antibiotic-resistant gram-negative bacteria or influenza.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-026.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00199985 Sep 20, 2014 Oct 20, 2014 View

Package 1

Mandatory forms

258511 RR_SF424_2_0-2.0.pdf

258511 PHS398_ResearchPlan_2_0-2.0.pdf

258511 PHS398_CoverPageSupplement_2_0-2.0.pdf

258511 RR_Budget_1_3-1.3.pdf

258511 RR_KeyPersonExpanded_2_0-2.0.pdf

258511 RR_OtherProjectInfo_1_3-1.3.pdf

258511 PerformanceSite_2_0-2.0.pdf

Optional forms

258511 PlannedReport-1.0.pdf

258511 PHS398_CumulativeInclusionReport-1.0.pdf

258511 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T14:10:28-05:00

Share This Post, Choose Your Platform!

About the Author: